🏅 FDA Orphan Designation
Verkazia
cyclosporine
Manufacturer: Harrow Eye, LLC
Indicated for:
FDA-Approved Indications (1)
Vernal keratoconjunctivitisOrphan Designation
Treatment of vernal keratoconjunctivitis (VKC) in children and adults
Indications & Usage
1 INDICATIONS AND USAGE Verkazia ophthalmic emulsion is indicated for the treatment of vernal keratoconjunctivitis (VKC) in children and adults. Verkazia ophthalmic emulsion is a calcineurin inhibitor immunosuppressant indicated for the treatment of vernal keratoconjunctivitis in children and adults ( 1 )
💙 Support Programs
View all →Verkazia
Harrow
Cyclosporine
Novartis
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.